Synthesis and Anti-Tumor Activities of 4-Anilinoquinoline Derivatives

Synthesis and Anti-Tumor Activities of 4-Anilinoquinoline Derivatives

Twenty-two 7-fluoro (or 8-methoxy)-4-anilinoquinolines compounds were designed and synthesized as potentially potent and selective antitumor inhibitors. All the prepared compounds were evaluated for their in vitro antiproliferative activities against the HeLa and BGC823 cell lines. Ten compounds (1a...

Full description

Bibliographic Details
Main Authors:	Dan Liu, Tian Luan, Jian Kong, Ying Zhang, Hai-Feng Wang
Format:	Article
Language:	English
Published:	MDPI AG 2015-12-01
Series:	Molecules
Subjects:	4-anilinoquinolines EGFR antitumor inhibitor
Online Access:	http://www.mdpi.com/1420-3049/21/1/21

Similar Items

Synthesis of novel 6,7-dimethoxy-4-anilinoquinolines as potent c-Met inhibitors
by: Qing-Wen Zhang, et al.
Published: (2019-01-01)

Optimization of 4-Anilinoquinolines as Dengue Virus Inhibitors
by: Pei-Tzu Huang, et al.
Published: (2021-12-01)

Utilization of Supervised Machine Learning to Understand Kinase Inhibitor Toxophore Profiles
by: Andrew A. Bieberich, et al.
Published: (2023-03-01)

Design, synthesis and antitumor activity of 5-trifluoromethylpyrimidine derivatives as EGFR inhibitors
by: Yaqing Zuo, et al.
Published: (2022-12-01)

Development of Novel Quinoline-Based Sulfonamides as Selective Cancer-Associated Carbonic Anhydrase Isoform IX Inhibitors
by: Moataz Shaldam, et al.
Published: (2021-10-01)

Design, Synthesis and Biological Evaluation of Novel Osimertinib-Based HDAC and EGFR Dual Inhibitors
by: Hang Dong, et al.
Published: (2019-06-01)

Synthesis, Characterization, and Biological Activity of a Novel Series of Benzo[4,5]imidazo[2,1-<i>b</i>]thiazole Derivatives as Potential Epidermal Growth Factor Receptor Inhibitors
by: Xinshan Deng, et al.
Published: (2019-02-01)

Synthesis of Novel Pyrazole Derivatives and Their Tumor Cell Growth Inhibitory Activity
by: Ying-Jie Cui, et al.
Published: (2019-01-01)

Discovery of YS-363 as a highly potent, selective, and orally eﬃcacious EGFR inhibitor
by: Pengxing He, et al.
Published: (2023-11-01)

Quinazolinone-Amino Acid Hybrids as Dual Inhibitors of EGFR Kinase and Tubulin Polymerization
by: Mohamed F. Zayed, et al.
Published: (2018-07-01)

Novel 2-(5-Aryl-4,5-Dihydropyrazol-1-yl)thiazol-4-One as EGFR Inhibitors: Synthesis, Biological Assessment and Molecular Docking Insights
by: Al-Warhi T, et al.
Published: (2022-05-01)

Uses of Cyanoacetylhydrazine in Heterocyclic Synthesis: Novel Synthesis of Pyrazole Derivatives with Anti-tumor Activities
by: Mahmoud A. Abdelaziz, et al.
Published: (2012-07-01)

Design, Synthesis and Evaluation of New Marine Alkaloid-Derived Pentacyclic Structures with Anti-Tumoral Potency
by: Sebastien Boucle, et al.
Published: (2015-01-01)

Synthesis and Biological Evaluation of Spirocyclic Chromane Derivatives as a Potential Treatment of Prostate Cancer
by: Li Feng, et al.
Published: (2021-05-01)

Design, Synthesis and Structure-Activity Relationships of Novel Diaryl Urea Derivatives as Potential EGFR Inhibitors
by: Nan Jiang, et al.
Published: (2016-11-01)

Synthesis and Antitumor Activity of Erlotinib Derivatives Linked With 1,2,3-Triazole
by: Peng Deng, et al.
Published: (2022-01-01)

Novel Indole-Containing Hybrids Derived from Millepachine: Synthesis, Biological Evaluation and Antitumor Mechanism Study
by: Baoxia Liang, et al.
Published: (2023-02-01)

Design, synthesis, and biological study of 4-[(2-nitroimidazole-1H-alkyloxyl)aniline]-quinazolines as EGFR inhibitors exerting cytotoxicities both under normoxia and hypoxia
by: Cheng W, et al.
Published: (2019-08-01)

Design, Synthesis, and Antitumor Activity of Olmutinib Derivatives Containing Acrylamide Moiety
by: Xiaohan Hu, et al.
Published: (2021-05-01)

Anilinoquinoline based inhibitors of trypanosomatid proliferation.
by: Lori Ferrins, et al.
Published: (2018-11-01)

Synthesis and Anti-tumor Activities of Novel [1,2,4]triazolo[1,5-a]pyrimidines
by: Ping Gong, et al.
Published: (2007-05-01)

Defucosylated Mouse–Dog Chimeric Anti-EGFR Antibody Exerts Antitumor Activities in Mouse Xenograft Models of Canine Tumors
by: Guanjie Li, et al.
Published: (2021-12-01)

Synthesis, anticancer and apoptosis-inducing activities of quinazoline–isatin conjugates: epidermal growth factor receptor-tyrosine kinase assay and molecular docking studies
by: Adel S. El-Azab, et al.
Published: (2017-01-01)

Design, synthesis, and biological evaluation of pyrido[2,3-d]pyrimidine and thieno[2,3-d]pyrimidine derivatives as novel EGFRL858R/T790M inhibitors
by: Jianfang Fu, et al.
Published: (2023-12-01)

Synthesis and Antiproliferative Potential of Thiazole and 4-Thiazolidinone Containing Motifs as Dual Inhibitors of EGFR and BRAF<sup>V600E</sup>
by: Alaa A. Hassan, et al.
Published: (2023-12-01)

Design, Synthesis and Biological Evaluation of Benzohydrazide Derivatives Containing Dihydropyrazoles as Potential EGFR Kinase Inhibitors
by: Hai-Chao Wang, et al.
Published: (2016-08-01)

Design, synthesis and biological evaluation of novel triazoloquinazolinone and imidazoquinazolinone derivatives as allosteric inhibitors of SHP2 phosphatase
by: Wenjun Ye, et al.
Published: (2022-05-01)

Synthesis of dichloroacetamides and study of their anti-tumor activity
by: L. M. Havryshchuk, et al.
Published: (2022-08-01)

Design, synthesis, and evaluation of novel coumarin-dithiocarbamate derivatives (IDs) as anti-colorectal cancer agents
by: Heping Zhu, et al.
Published: (2021-01-01)

Potential Therapeutic Strategy for EGFR-Mutant Lung Cancer With Concomitant EML4-ALK Rearrangement—Combination of EGFR Tyrosine Kinase Inhibitors and ALK Inhibitors
by: Ming-Hung Huang, PhD, et al.
Published: (2022-11-01)

Structure–Activity Relationship Studies Based on Quinazoline Derivatives as EGFR Kinase Inhibitors (2017–Present)
by: Alexandru Șandor, et al.
Published: (2023-04-01)

Discovery of novel 2,3,4,5-tetrahydrospiro[benzo[c]azepine-1,1’-cyclohexan]-5-ol derivatives as PARP-1 inhibitors
by: Ling Yu, et al.
Published: (2023-10-01)

Advances in antitumor research of CA-4 analogs carrying quinoline scaffold
by: Chao Wang, et al.
Published: (2022-10-01)

Design, synthesis and biological evaluation of 9-aryl-5H-pyrido[4,3-b]indole derivatives as potential tubulin polymerization inhibitors
by: Lingyu Shi, et al.
Published: (2022-09-01)

Synthesis of Caffeic Acid Amides Bearing 2,3,4,5-Tetra-hydrobenzo[b][1,4]dioxocine Moieties and Their Biological Evaluation as Antitumor Agents
by: Ji-Wen Yuan, et al.
Published: (2014-06-01)

Structure–Activity Relationship of PAD4 Inhibitors and Their Role in Tumor Immunotherapy
by: Yijiang Jia, et al.
Published: (2024-02-01)

Design, synthesis and biological evaluation of pyrazolo[3,4-d]pyridazinone derivatives as covalent FGFR inhibitors
by: Xiaowei Wu, et al.
Published: (2021-03-01)

Design, Synthesis, and Evaluation of Benzoheterocyclic-Containing Derivatives as Novel HDAC1 Inhibitors
by: Min-Ru Jiao, et al.
Published: (2022-03-01)

Design, Synthesis, In Vitro Anticancer Evaluation and Molecular Modelling Studies of 3,4,5-Trimethoxyphenyl-Based Derivatives as Dual EGFR/HDAC Hybrid Inhibitors
by: Tarek S. Ibrahim, et al.
Published: (2021-11-01)

The Crystal Structure of 2-Amino-4-(2,3-Dichlorophenyl)-6-Methoxy-4<i>H</i>-Benzo[<i>h</i>]chromene-3-Carbonitrile: Antitumor and Tyrosine Kinase Receptor Inhibition Mechanism Studies
by: Ahmed M. El-Agrody, et al.
Published: (2022-05-01)